MONITORING PLASMINOGEN AND PLASMIN IN PLASMA OF CHILDREN WITH NEPHROBLASTOMA DURING TREATMENT
Important indicator of the effectiveness of chemotherapy (ratio of the content of plasminogen to plasmin activity in plasma) was identified in children with nephroblastoma before treatment. We found out, that increasing the ratio «plasminogen / plasmin « above the norm is a favorable prognostic factor. It had previously been used to monitor the effectiveness of treatment of children with neuroblastoma. Expanding the area of its application may be useful for application in pediatric cancer institutions. Monitoring plasminogen and plasmin in plasma of children with nephroblastoma during treatment.